MTT assay to evaluate the cytotoxic potential of a drug

被引:311
作者
Bahuguna, Ashutosh [1 ]
Khan, Imran [1 ]
Bajpai, Vivek K. [2 ]
Kang, Sun Chul [1 ]
机构
[1] Daegu Univ, Dept Biotechnol, Gyongsan 712714, Gyeongbuk, South Korea
[2] Yeungnam Univ, Dept Appl Microbiol & Biotechnol, Gyongsan 712749, Gyeongbuk, South Korea
关键词
CELL-LINES; SENSITIVITY; GROWTH;
D O I
10.3329/bjp.v12i2.30892
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Quantification of cell viability and proliferation form the fundamental for numerous in vitro assays in response to external factors. An MTT assay is a colorimetric assay based on assessing the cell metabolic activity. A549 Lung adenocarcinoma cell line was used to see the cytotoxic potential of a new drug for initial screening of apoptosis or necrosis. The biochemical mechanism behind the MTT assay involves NAD(P) H-dependent cellular oxidoreductase enzyme that converts the yellow tetrazolium MTT [3-(4, 5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide] into insoluble (E,Z)-5-(4,5-dimethylthiazol-2-yl)1,3-diphenylformazan (formazan). The formed formazan can be dissolved with dimethyl sulfoxide (DMSO) to give a purple color with characteristic absorption at 540 nm. Intensity of purple color is directly proportional to the cell number and thus indicating the cell viability.
引用
收藏
页码:115 / 118
页数:4
相关论文
共 8 条
[1]  
ALLEY MC, 1986, P AM ASSOC CANC RES, V27, P389
[2]  
Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7
[3]   In vitro cytotoxicity assays: Comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride [J].
Fotakis, G ;
Timbrell, JA .
TOXICOLOGY LETTERS, 2006, 160 (02) :171-177
[4]  
Morgan D M, 1998, Methods Mol Biol, V79, P179
[6]  
Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111
[7]  
van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20
[8]   A TETRAZOLIUM-BASED COLORIMETRIC MTT ASSAY TO QUANTITATE HUMAN MONOCYTE MEDIATED CYTOTOXICITY AGAINST LEUKEMIC-CELLS FROM CELL-LINES AND PATIENTS WITH ACUTE MYELOID-LEUKEMIA [J].
VANDELOOSDRECHT, AA ;
BEELEN, RHJ ;
OSSENKOPPELE, GJ ;
BROEKHOVEN, MG ;
LANGENHUIJSEN, MMAC .
JOURNAL OF IMMUNOLOGICAL METHODS, 1994, 174 (1-2) :311-320